Skip to main content

Market Overview

Mid-Day Market Update: Bed Bath & Beyond Drops On Earnings Miss; DelMar Pharmaceuticals Shares Plunge

Share:

Midway through trading Wednesday, the Dow traded down 0.01 percent to 22,370.10 while the NASDAQ declined 0.11 percent to 6,454.34. The S&P also fell, dropping 0.01 percent to 2,506.45.

Leading and Lagging Sectors

On Wednesday, the energy shares surged 0.45 percent. Meanwhile, top gainers in the sector included Contango Oil & Gas Company (NYSE: MCF), up 11 percent, and Bristow Group Inc (NYSE: BRS), up 8 percent.

In trading on Wednesday, technology shares fell 0.36 percent. Meanwhile, top losers in the sector included MakeMyTrip Limited (NASDAQ: MMYT), down 7 percent, and Western Digital Corp (NASDAQ: WDC) down 4 percent.

Top Headline

General Mills, Inc. (NYSE: GIS) reported weaker-than-expected earnings for its first quarter.

General Mills posted Q1 adjusted earnings of $0.71 per share on revenue of $3.77 billion. However, analysts were expecting earnings of $0.76 per share on sales of $3.79 billion.

Equities Trading UP

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 40 percent to $105.03 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

Shares of DelMar Pharmaceuticals Inc (NASDAQ: DMPI) got a boost, shooting up 83 percent to $2.07 after announcing issuance of new patent for VAL-08.

Gemphire Therapeutics Inc (NASDAQ: GEMP) shares were also up, gaining 11 percent to $10.70 after the company reported plans to advance gemcabene into Phase 3 development.

Equities Trading DOWN

Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares dropped 16 percent to $22.83 as the company reported downbeat earnings for its third quarter.

Shares of Maxwell Technologies Inc. (NASDAQ: MXWL) were down 15 percent to $5.37. Maxwell reported amended terms for deal with Viex Capital and announced a proposed offering of $50 million convertible senior notes due 2022.

Iovance Biotherapeutics Inc (NASDAQ: IOVA) was down, falling around 11 percent to $7.57. Iovance Biotherapeutics reported a $50 million offering of common stock.

Commodities

In commodity news, oil traded up 1.15 percent to $50.05 while gold traded up 0.45 percent to $1,316.50.

Silver traded up 0.38 percent Wednesday to $17.345, while copper fell 0.19 percent to $2.964.

Eurozone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.13 percent, the Spanish Ibex Index fell 1.17 percent, while Italy’s FTSE MIB Index declined 0.35 percent. Meanwhile the German DAX declined 0.03 percent, and the French CAC 40 gained 0.03 percent while U.K. shares fell 0.15 percent.

Economics

The MBA's index of mortgage application activity rose 9.7 percent for the latest week.

Existing home sales declined 1.7 percent to an annual rate of 5.35 million in August. However, economists were expecting a 5.46 million rate.

Domestic crude supplies rose 4.59 million barrels for the week ended September 15, the U.S. Energy Information Administration reported. Analysts expected a gain of 3.49 million barrels. Gasoline stockpiles dropped 2.13 million barrels, while distillate stockpiles slipped 5.69 million barrels for the week.

The Federal Open Market Committee will announce its policy decision at 2:00 p.m. ET.

The Fed Chair Janet Yellen will hold a press conference at 2:30 p.m. ET.

 

Related Articles (ALNY + BBBY)

View Comments and Join the Discussion!

Posted-In: Mid-Day Market UpdateNews Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com